Dr. Zeev Rosberger

Dr. Zeev Rosberger

Board of Directors
As Vice-President of the organization, Dr. Rosberger is a clinical psychologist and leading Canadian researcher, primarily in the area of psychosocial oncology. He is Senior Investigator at the Lady Davis Institute for Medical Research, Jewish General Hospital; and Associate Professor in the Departments of Psychology, Psychiatry and Oncology at McGill University, in Montreal Canada. For more than 25 years until 2017, he served as the Chief of the Department of Psychology at the Jewish General Hospital. He led the development of the Louise Granofsky-Psychosocial Oncology Program in the Segal Cancer Centre of the Jewish General Hospital.

His current primary research focus is on the prevention of Human Papillomavirus (HPV) transmission through the study of HPV vaccine decision-making of parents for their young children, and adolescents and young adults who are at higher risk of infection. He is also currently co-leading a major quality initiative to improve patient care in oncology through the implementation and evaluation of electronic distress screening and patient reported outcomes measures. Additionally, he is a co-investigator with colleagues in several projects: psychosocial distress in head and neck cancer patients; understanding fertility issues among boys and men in the general population and those experiencing a cancer diagnosis and the development of digital technology to improve knowledge and provide support; implementation and evaluation of a peer-support intervention for women with newly diagnosed breast cancer.

Publications

Correction to: The patient advisor, an organizational resource as a lever for an enhanced oncology patient experience (PAROLEonco): a longitudinal multiple case study protocol

M. P. Pomey 1,2,3,4,5*, M. de Guise 5, M. Desforges 6, K. Bouchard 7, C. Vialaron 1, L. Normandin 1, M. Iliescu-Nelea 1, I. Fortin 6, I. Ganache 5, C. Régis 8, Z. Rosberger 9, D. Charpentier 10, L. Bélanger 7, M. Dorval 7,11,12,13, D. P. Ghadiri 14, M. Lavoie-Tremblay 15,16, A. Boivin 1,2,4, J. F. Pelletier 4,17, N. Fernandez 4 and A. M. Danino 1,10

COVID-19 Won’t Be the Last (Or Worst) Pandemic: It’s Time to Build Resilience Into Our Cervical Cancer Elimination Goals

Marc Steben, MD; 1 Teresa Norris; 2 Zeev Rosberger, PhD 3, on behalf of HPV Global Action *

1 Co-President, HPV Global Action; Chair, Canadian Network on HPV Prevention; Associate professor, School of Public Health, Universite de Montreal
2 Founder and President, HPV Global Action
3 Vice-President, HPV Global Action; Senior Investigator, Lady Davis Institute for Medical Research; Associate Professor, Departments of Psychology, Psychiatry and Oncology, McGill University

The patient advisor, an organizational resource as a lever for an enhanced oncology patient experience (PAROLEonco): a longitudinal multiple case study protocol

M. P. Pomey 1,2,3,4,5*, M. de Guise 5, M. Desforges 6, K. Bouchard 7, C. Vialaron 1, L. Normandin 1, M. Iliescu-Nelea 1, I. Fortin 6, I. Ganache 5, C. Régis 8, Z. Rosberger 9, D. Charpentier 10, L. Bélanger 7, M. Dorval 7,11,12,13, D. P. Ghadiri 14, M. Lavoie-Tremblay 15,16, A. Boivin 1,2,4, J. F. Pelletier 4,17, N. Fernandez 4 and A. M. Danino 1,10

EN